CTPS2 Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)

N° du produit ABIN2712617

Détail du produit

Antigène: CTPS2 (CTP Synthase II (CTPS2))

Type de proteíne: Recombinant

Attributs du protein: Transcript Variant 2

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette CTPS2 protéine est marqué à la Myc-DYKDDDDK Tag.

Application: Antibody Production (AbP), Standard (STD)

Attributs du produit:

• Recombinant human CTP synthase 2 (transcript variant 2) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: CTPS2 (CTP Synthase II (CTPS2))

Autre désignation: Ctp Synthase 2 (CTPS2 Produits)

Synonymes: A830031M15Rik Protein, AI326475 Protein, Ctpsh Protein, CTP synthase 2 L homeolog Protein, CTP synthase 2 Protein, cytidine 5'-triphosphate synthase 2 Protein, ctps2.L Protein, CTPS2 Protein, ctps2 Protein, Ctps2 Protein

Sujet: The protein encoded by this gene catalyzes the formation of CTP from UTP with the concomitant deamination of glutamine to glutamate. This protein is the rate-limiting enzyme in the synthesis of cytosine nucleotides, which play an important role in various metabolic processes and provide the precursors necessary for the synthesis of RNA and DNA. Cancer cells that exhibit increased cell proliferation also exhibit an increased activity of this encoded protein. Thus, this protein is an attractive target for selective chemotherapy. Alternative splicing results in multiple transcript variants.

Poids moléculaire: 65.5 kDa

NCBI Accession: NP_787055

Pathways: Ribonucleoside Biosynthetic Process